These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1623765)

  • 1. Ethical relationships between drug companies and the medical profession.
    Rosner F
    Chest; 1992 Jul; 102(1):266-9. PubMed ID: 1623765
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.
    Orlowski JP; Wateska L
    Chest; 1992 Jul; 102(1):270-3. PubMed ID: 1623766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines.
    Rosner F
    Mt Sinai J Med; 1995 Nov; 62(6):427-30. PubMed ID: 8692156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conflict of interest in continuing medical education - Studies on certified CME courses].
    Lenzen LM; Weidringer JW; Ollenschläger G
    Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():60-8. PubMed ID: 26875037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMA forges ahead. Unveiling of educational campaign paid by drug industry triggers new criticism.
    Romano M
    Mod Healthc; 2001 Sep; 31(37):22-3. PubMed ID: 11573355
    [No Abstract]   [Full Text] [Related]  

  • 7. [Editorial: Hebebrand, J., Blanz, B., Herpertz-Dahlmann, B. & Lehmkuhl, G. 2012. Increase in the abundance of medical treatments, ethical principles and conflicts of interest in cooperation with the pharmaceutical industry].
    Frank R
    Z Kinder Jugendpsychiatr Psychother; 2013 Mar; 41(2):145-9. PubMed ID: 23425616
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between industry payments and prescriptions of long-acting insulin: An observational study with propensity score matching.
    Inoue K; Tsugawa Y; Mangione CM; Duru OK
    PLoS Med; 2021 Jun; 18(6):e1003645. PubMed ID: 34061852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and Japan.
    Rodwin MA
    J Law Med Ethics; 2011; 39(4):662-70. PubMed ID: 22084852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries.
    Mitchell AP; Winn AN; Dusetzina SB
    JAMA Intern Med; 2018 Jun; 178(6):854-856. PubMed ID: 29630687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future directions in industry funding of continuing medical education.
    Steinbrook R
    Arch Intern Med; 2011 Feb; 171(3):257-8. PubMed ID: 21325116
    [No Abstract]   [Full Text] [Related]  

  • 12. Doctors and the drug makers.
    Rawlins MD
    Lancet; 1984 Aug; 2(8397):276-8. PubMed ID: 6146822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations in the relationship between the American College of Chest Physicians and industry.
    Lever A
    Chest; 2001 Apr; 119(4):1257-9. PubMed ID: 11296196
    [No Abstract]   [Full Text] [Related]  

  • 14. AMA's gift guidelines.
    Conley RB
    Food Drug Cosmet Med Device Law Dig; 1993; 10():19-27. PubMed ID: 11654936
    [No Abstract]   [Full Text] [Related]  

  • 15. Industry support of physician education in the USA.
    Fleischman W; Ross JS
    J Epidemiol Community Health; 2017 Mar; 71(3):213-216. PubMed ID: 27612981
    [No Abstract]   [Full Text] [Related]  

  • 16. The drug industry and medical practice--the case of menopausal hormone therapy in Estonia.
    Hemminki E; Karttunen T; Hovi SL; Karro H
    Soc Sci Med; 2004 Jan; 58(1):89-97. PubMed ID: 14572923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution?
    Insel TR
    JAMA; 2010 Mar; 303(12):1192-3. PubMed ID: 20332407
    [No Abstract]   [Full Text] [Related]  

  • 18. No more free lunches.
    Abbasi K; Smith R
    BMJ; 2003 May; 326(7400):1155-6. PubMed ID: 12775587
    [No Abstract]   [Full Text] [Related]  

  • 19. Physician-industry relations. Part 2: organizational issues.
    Coyle SL;
    Ann Intern Med; 2002 Mar; 136(5):403-6. PubMed ID: 11874315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical commerce, physician entrepreneurialism, and conflicts of interest.
    Rodwin MA
    Camb Q Healthc Ethics; 2007; 16(4):387-97; discussion 439-42. PubMed ID: 18018918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.